NALOXONE HYDROCHLORIDE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8477 for the delivery of NALOXONE HYDROCHLORIDE INJECTION, identified by NSN 6505015334126 and PR 7017699728. The total contract value is $172.44, with the award issued on July 30, 2026, and the order placed under the parent contract SPE2DX25D9900. The item is intended for federal use, and the performance location is not specified beyond the United States. The awardee, identified by CAGE code 1UNB0, is responsible for fulfilling this delivery as part of the Department of Defense’s medical supply chain, with no set-aside classification indicated. The contract was posted on the DIBBS system and can be referenced via the provided UI link.
General Info
Agency
Contract Value
$172.44NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
